By Barron's | April 23, 2019
Wall Street analysts are telling health-care company shareholders that they shouldn’t worry about Medicare for All.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...
A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...